Acta Scientific Gastrointestinal Disorders (ASGIS)(ISSN: 2582-1091)

Research Article Volume 4 Issue 6

An Analysis of Gastroentereopancreatic Neuroendocrine Tumours at a Tertiary Care Hospital in Southern India

Vinay K1, Balaji Jayasankar2* and Sonali V Huilgol3

1Consultant Surgeon, Columbia Asia Hospital, Mysore, India
2Registrar, General and Colorectal Surgery, Maidstone and Tunbridge Wells NHS, United Kingdom
3Consultant Surgeon, Mysore Medical College and Research Institute, Mysore, India

*Corresponding Author: Balaji Jayasankar, Registrar, General and Colorectal Surgery, Maidstone and Tunbridge Wells NHS, United Kingdom.

Received: March 24, 2021; Published: May 28, 2021


Introduction: There is limited data available on epidemiology and clinicopathological patterns of gastroenteropancreatic neuroendocrine tumours (GEP NET) in India. Due to increased availability of advanced endoscopic and radiological imaging, the diagnosis of benign and incidentally identified lesions has also increased over the past decades. Curative surgery is often not feasible since most patients present with metastases at diagnosis. We sought to study the demographics and the behaviour of the tumour.

Methods: The present study is an ambispective study of 25 patients diagnosed to have GEP NETs, treated at over a period of 5 years. Our study focussed on the distribution, epidemiology, treatment and outcomes.

Results: The mean age of presentation was 51 years with a female preponderance of 52%. Most common site of origin was pancreas (56%) followed by duodenum (32%). Abdominal pain (68%) was the most common clinical presentation followed by vomiting (8%). 17 patients underwent surgery or endoscopic resection. 8 patients underwent medical management. All 25 patients survived and discharged from hospital after respective treatment. There were no deaths recorded in these patients during the hospital stay, however on follow up 5 patients reported mortality in a span of 18 months.

Conclusion: The majority of GEP NET will benefit with a timely surgical intervention along with a sustained medical management. A more robust epidemiological study will help us to understand the burden of this disease better amongst our population.

Keywords: Gastroenteropancreatic Neuroendocrine Tumours (GEP NET); Duodenum; Abdominal Pain


  1. Modlin IM., et al. “Gastroenteropancreatic neuroendocrine tumours”. Lancet Oncology1 (2008): 61-72.
  2. Soga J and Tazawa K. “Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases”. Cancer 4 (1971): 990.
  3. Starker LF and Carling T. “Molecular genetics of gastroenteropancreatic neuroendocrine tumors”. Current Opinion in Oncology 1 (2009): 29-33.
  4. Yao JC., et al. “One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumours in 35,825 cases in the United States”. Journal of Clinical Oncology 18 (2008): 3063-3072.
  5. Oberg K and Jelic S. “Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up”. Annals of Oncology 2 (2008): ii104-ii105.
  6. McEntee GP., et al. “Cytoreductive hepatic surgery for neuroendocrine tumors”. Surgery 6 (1990): 1091-1096.
  7. Moller LN., et al. “Somatostatin receptors”. Biochimica et Biophysica Acta 1 (2003): 1-84.
  8. Kulke MH. “Neuroendocrine tumors: is there a standard treatment?” Gastrointestinal Cancer Research 3 (2008): 152-153.
  9. Eriksson B., et al. “Consensus guidelines for the management of patients with digestive neuroendocrine tumors-well differentiated jejunal - ileal tumor/carcinoma”. Neuroendocrinology1 (2008): 8-19.
  10. Amarapurkar DN., et al. “A retrospective clinico-pathological analysis of neuroendocrine tumors of the gastrointestinal tract”. Tropical Gastroenterology 2 (2010): 101-104.
  11. Jiao X., et al. “Clinicopathological features and survival analysis of gastroenteropancreatic neuroendocrine neoplasms: a retrospective study in a single center of China”. Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu3 (2015): 258-266.
  12. Estrozi B and Bacchi CE. “Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases”. Clinics (Sao Paulo, Brazil)10 (2011): 1671-1675.


Citation: Balaji Jayasankar., et al. “An Analysis of Gastroentereopancreatic Neuroendocrine Tumours at a Tertiary Care Hospital in Southern India”. Acta Scientific Gastrointestinal Disorders 4.6 (2021): 74-77.


Copyright: © 2021 Balaji Jayasankar., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate35%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US